Why the study?
It was unknown whether insulin resistance assessed by HOMA-IR or the TyG index is more closely related to specific markers of vascular dysfunction.
Is the triglyceride-glucose (TyG) index or homeostasis model assessment of insulin resistance (HOMA-IR) more closely associated with specific markers of macro- and microvascular dysfunction?
Is the triglyceride-glucose (TyG) index or homeostasis model assessment of insulin resistance (HOMA-IR) more closely associated with specific markers of macro- and microvascular dysfunction?
Both TyG index and HOMA-IR are associated with vascular dysfunction, but the TyG index demonstrates a stronger independent association with macrovascular arterial stiffness while HOMA-IR is more closely linked to microvascular albuminuria.
TyG index and HOMA-IR may mark distinct vascular pathways; leaves open incremental utility for risk stratification in prospective cohorts.
Introduction: While insulin resistance (IR) is an established risk factor for cardiovascular disease, vascular dysfunction represents a critical early pathological link. Although prior studies support the association between IR and vascular dysfunction, it remains unknown whether IR assessed by homeostasis model assessment of IR (HOMA-IR) or the triglyceride-glucose index (TyG index) is more closely related to specific markers of vascular dysfunction. Methods: A total of 2,278 participants (59.3% women; average age, 56.7 ± 11.0 years) were recruited in this study. The HOMA-IR and TyG index was calculated using (fasting insulin [μIU/mL] × fasting glucose [mmol/L]/22.5) and ln (fasting triglyceride [mg/dL] × fasting glucose [mg/dL]/2), respectively. Vascular measurements included brachial-ankle pulse wave velocity (baPWV), cardio-ankle vascular index (CAVI), and urinary albumin-to-creatinine ratio (UACR), representing macro- and microvascular dysfunction, respectively. Results: Irrespective of the assessment methods of IR, both the TyG index and HOMA-IR were all significantly associated with the vascular indices before (p < 0.001) and after full adjustment (p ≤ 0.041). The standardized regression coefficients of the vascular dysfunction with the TyG index were comparable to those with the HOMA-IR after adjustment for various confounders (0.07–15.8 versus 0.05–18.2; Pcompare ≥ 0.108). In multivariable logistic regression analysis, the TyG index was significantly associated with higher risk of arterial stiffness (odds ratio [OR] = 1.37 and 1.26 for abnormal baPWV and CAVI, respectively; p ≤ 0.035), while the HOMA-IR was tightly associated with higher risk of abnormal CAVI (OR = 1.54; p < 0.001) and albuminuria (OR = 1.40; p = 0.006). Further subgroup analyses showed that a more significant association between the TyG index and the prevalence of increased arterial stiffness was observed in women and nondiabetic participants, and participants without chronic kidney disease (CKD) (p ≤ 0.025), while a more significant association between the HOMA-IR and the prevalence of abnormal CAVI and albuminuria was detected in younger individuals, females, normotensive, or normoglycemic subjects (p ≤ 0.035). Conclusion: The TyG index demonstrated a stronger association with arterial stiffness (baPWV) than HOMA-IR, whereas the HOMA-IR showed a more pronounced association with albuminuria, especially in women.
No takes yet. Share an insight, caveat, or question.
Liang et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: